General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Nipro(MODEST), Janssen Pharmaceuticals, Inc(MODEST), Philips(NONE) EQUITY INTERESTS/STOCK OPTIONS: Johnson & Johnson(SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Peytant(NONE) RESEARCH/RESEARCH GRANTS: Avantec(NONE), Mercantor MedSystems(NONE)

View Full Disclosure